Jake Haubner

Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis

B. Neuschwander‐Tetri, B. Ulmasov, D. Ford, 2021, Molecular metabolism.

Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases

A. Chakraborty, S. Mukherjee, Jake Haubner, 2020, Molecules.

Whole Body Ip6k1 Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction

M. Chakraborty, A. Chakraborty, S. Ghoshal, 2022, International journal of molecular sciences.

Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivo

B. Neuschwander‐Tetri, B. Ulmasov, D. Ford, 2023, Molecular metabolism.

The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling

J. Barrow, M. Chakraborty, A. Chakraborty, 2023, Biomolecules.